Connecticut lawmakers are expected soon to pass a significantly revised version of Gov. Ned Lamont’s (D) health care cost reduction bill stripped of language that would have barred drug manufacturers from limiting use of contract pharmacies and imposing other conditions
…
The Louisiana Senate voted unanimously Sunday to pass and send to Gov. John Bel Edwards (D) a bill prohibiting drug manufacturer limits on 340B contract pharmacy relationships and pharmacy benefit manager encroachment on health care providers’ 340B program revenues.
Edwards
…
New York State is appealing a state trial court’s dismissal of its antitrust case against CVS Health that alleges the pharmacy giant unlawfully forces 340B covered entities to use its 340B third party administrator Wellpartner in order to contract with
…
The U.S. Department of Health and Human Services and the Health Resources and Services Administration “are unable to predict” when they will finally replace HRSA’s 340B administrative dispute resolution process, the government said in a recent legal filing.
The government
…
The U.S. Health Resources and Services Administration yesterday posted notices of refunds for 340B overcharges from drug manufacturers Lilly, Novo Nordisk, and Neurocrine and a notice from Amneal about product NDC changes.
Lilly
Lilly’s May 30 notice covers purchases
…
Health care providers in Guam eligible to participate in the 340B program may do so immediately, rather than having to wait for the next normal quarterly registration period July 1-15, the U.S. Health Resources and Services Administration said yesterday.
Secretary
…
ASAP 340B, the group that drug manufacturers and community health centers formed to advance a joint 340B reform agenda, recently released a two-page explainer on how their plan would change the 340B patient definition. Under it, fewer drugs prescribed at
…
Drug manufacturer Merck is paying refunds for overcharges on 340B drugs purchased during the first two quarters of 2020.
Merck recently asked the U.S. Health Resources and Services Administration to post notices about its 340B ceiling price recalculations on the
…
Publisher’s Note: Since we first published this piece by Jennifer Lockwood of Ravin Consultants, there has been an important development that is addressed at the end of the story. We thank Jennifer and her team for alerting us and recommending that we
…
Companion bills in the Massachusetts House and Senate would restore the 340B program’s intent by stopping pharmacy benefit manager discrimination against any 340B covered entities and their contract pharmacies, the sponsor of the state Senate bill said during a recent
…
×
*Sign up for news summaries and alerts from 340B Report
